Business ❯Pharmaceutical Industry
Sales Projections Sales Performance Investor Relations Vaccine Market Revenue Forecasting Revenue Projections Investor Reactions
The MHRA authorizes Blenrep for relapsed or refractory multiple myeloma based on pivotal Phase 3 trial data, with reviews underway in 14 countries.